Published by Josh White on 20th September 2023
(Sharecast News) - Clinical-stage biopharmaceutical company Poolbeg Pharma announced the receipt of a notice of allowance from the Japanese Patent Office for its Immunomodulator I patent application on Wednesday.
URL: http://www.digitallook.com/dl/news/story/33783083/...